Compare SYRE & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYRE | CSTM |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | France |
| Employees | N/A | 11500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2015 | 2012 |
| Metric | SYRE | CSTM |
|---|---|---|
| Price | $43.49 | $24.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $55.57 | $29.00 |
| AVG Volume (30 Days) | 655.8K | ★ 2.3M |
| Earning Date | 05-19-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 405.26 |
| EPS | N/A | ★ 1.92 |
| Revenue | N/A | ★ $8,449,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.46 |
| P/E Ratio | ★ N/A | $13.50 |
| Revenue Growth | N/A | ★ 15.19 |
| 52 Week Low | $10.91 | $7.33 |
| 52 Week High | $45.76 | $27.25 |
| Indicator | SYRE | CSTM |
|---|---|---|
| Relative Strength Index (RSI) | 71.28 | 54.34 |
| Support Level | $14.62 | $22.14 |
| Resistance Level | N/A | $27.25 |
| Average True Range (ATR) | 2.29 | 1.18 |
| MACD | 0.74 | -0.09 |
| Stochastic Oscillator | 79.60 | 47.67 |
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.